These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33385593)

  • 1. Structural and functional correlates of subthalamic deep brain stimulation-induced apathy in Parkinson's disease.
    Boon LI; Potters WV; Zoon TJC; van den Heuvel OA; Prent N; de Bie RMA; Bot M; Schuurman PR; van den Munckhof P; Geurtsen GJ; Hillebrand A; Stam CJ; van Rootselaar AF; Berendse HW
    Brain Stimul; 2021; 14(1):192-201. PubMed ID: 33385593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
    Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy following deep brain stimulation in Parkinson's disease visualized by 7-Tesla MRI subthalamic network analysis.
    Zoon TJC; Mathiopoulou V; van Rooijen G; van den Munckhof P; Denys DAJP; Schuurman PR; de Bie RMA; Bot M
    Brain Stimul; 2023; 16(5):1289-1291. PubMed ID: 37619890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis.
    Zoon TJC; van Rooijen G; Balm GMFC; Bergfeld IO; Daams JG; Krack P; Denys DAJP; de Bie RMA
    Mov Disord; 2021 Feb; 36(2):317-326. PubMed ID: 33331023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson's disease: a study protocol.
    Zoon TJC; van Rooijen G; Contarino MF; van der Gaag S; Zutt R; van Asseldonk JT; van den Munckhof P; Schuurman PR; Denys DAJP; de Bie RMA
    Trials; 2024 Feb; 25(1):104. PubMed ID: 38308317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
    Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
    Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetoencephalography to measure the effect of contact point-specific deep brain stimulation in Parkinson's disease: A proof of concept study.
    Boon LI; Potters WV; Hillebrand A; de Bie RMA; Bot M; Richard Schuurman P; van den Munckhof P; Twisk JW; Stam CJ; Berendse HW; van Rootselaar AF
    Neuroimage Clin; 2023; 38():103431. PubMed ID: 37187041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
    Santin MDN; Voulleminot P; Vrillon A; Hainque E; Béreau M; Lagha-Boukbiza O; Wirth T; Montaut S; Bardinet E; Kyheng M; Rolland AS; Voirin J; Drapier S; Durif F; Eusebio A; Giordana C; Auzou N; Houeto JL; Hubsch C; Jarraya B; Laurencin C; Maltete D; Meyer M; Rascol O; Rouaud T; Tir M; Moreau C; Corvol JC; Proust F; Grabli D; Devos D; Tranchant C; Anheim M;
    Mov Disord; 2021 Mar; 36(3):750-757. PubMed ID: 33022101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Subthalamic Deep Brain Stimulation on Apathy in Parkinson's Disease Patients.
    Oner OG; Jafarova S; Ozden H; Seker A; Gunal DI
    Turk Neurosurg; 2024; 34(4):672-677. PubMed ID: 38874248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric effects of subthalamic deep brain stimulation.
    Mosley PE; Akram H
    Handb Clin Neurol; 2021; 180():417-431. PubMed ID: 34225945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic Stimulation for Camptocormia in Parkinson's Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness.
    Lai Y; Song Y; Huang P; Wang T; Wang L; Pan Y; Sun Q; Sun B; Zhang C; Li D
    J Parkinsons Dis; 2021; 11(1):199-210. PubMed ID: 33325395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.
    Gesquière-Dando A; Guedj E; Loundou A; Carron R; Witjas T; Fluchère F; Delfini M; Mundler L; Regis J; Azulay JP; Eusebio A
    Mov Disord; 2015 Nov; 30(13):1767-76. PubMed ID: 26228098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.